Author

Alieu Amara

Observed names: A Amara, A. Amara, Alieu Ammara, Alieu B Amara, Alieu B. Amara, Amara Alieu, Amara, Alieu, Amara, Alieu Badarr

Observed institutions: Universitat de Vic - Universitat Central de Catalunya, University of Liverpool, Chelsea and Westminster Hospital NHS Foundation Trust, Royal Liverpool University Hospital, Adekunle Ajasin University, UNSW Sydney, St Mary's Hospital, St Stephen’s AIDS Trust, Obafemi Awolowo University, Imperial College London

ORCID: 0000-0002-1137-2948

Observed ORCID: 0000-0002-1137-2948

OpenAlex ID: A5022857046

Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)

2019 · Catriona Waitt, Catherine Orrell, et al. · PLoS Medicine · 109

PDF

The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva

2021 · Alieu Amara, Sujan Dilly Penchala, et al. · Journal of Pharmaceutical and Biomedical Analysis · 83

Tenofovir, Emtricitabine Intracellular and Plasma, and Efavirenz Plasma Concentration Decay Following Drug Intake Cessation

2012 · Akil Jackson, Graeme Moyle, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 53

Long-Term Evaluation of Electrospray Ionization Mass Spectrometric Analysis of Glycated Hemoglobin

2001 · Norman B Roberts, Alieu B Amara, et al. · Clinical Chemistry · 52

Pharmacogenetics of pregnancy‐induced changes in efavirenz pharmacokinetics

2015 · A Olagunju, O Bolaji, et al. · Clinical Pharmacology & Therapeutics · 48

Pharmacokinetics of Once-Daily Darunavir-Ritonavir and Atazanavir-Ritonavir over 72 Hours following Drug Cessation

2011 · Marta Boffito, Akil Jackson, et al. · Antimicrobial Agents and Chemotherapy · 44

PDF

The development and application of a novel LC–MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma

2016 · Sujan Dilly Penchala, Sandra Fawcett, et al. · Journal of Chromatography B · 40

Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS

2014 · Adeniyi Olagunju, Oluseye O. Bolaji, et al. · Journal of Antimicrobial Chemotherapy · 40

PDF

Breast Milk Pharmacokinetics of Efavirenz and Breastfed Infants' Exposure in Genetically Defined Subgroups of Mother-Infant Pairs: An Observational Study

2015 · Adeniyi Olagunju, Oluseye Bolaji, et al. · Clinical Infectious Diseases · 39

PDF

Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake

2015 · Emilie Elliot, Alieu Amara, et al. · Journal of Antimicrobial Chemotherapy · 37

Pharmacokinetics of Lamivudine and Lamivudine-Triphosphate after Administration of 300 Milligrams and 150 Milligrams Once Daily to Healthy Volunteers: Results of the ENCORE 2 Study

2011 · Laura J. Else, Akil Jackson, et al. · Antimicrobial Agents and Chemotherapy · 37

Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC–MS/MS

2017 · Catriona Waitt, Sujan Diliiy Penchala, et al. · Journal of Chromatography B · 34

PDF

Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults

2012 · Mohammed Lamorde, Pauline Byakika-Kibwika, et al. · AIDS Research and Treatment · 33

PDF

Albumin overload induces adaptive responses in human proximal tubular cells through oxidative stress but not via angiotensin II type 1 receptor

2007 · Liliana Shalamanova, Frank McArdle, et al. · American Journal of Physiology-Renal Physiology · 32

Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1

2020 · Laura Dickinson, Stephen Walimbwa, et al. · Clinical Infectious Diseases · 31

PDF

A Validated Method for Quantification of Efavirenz in Dried Blood Spots Using High-Performance Liquid Chromatography–Mass Spectrometry

2014 · Alieu B. Amara, Laura J. Else, et al. · Therapeutic Drug Monitoring · 31

Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine

2018 · Stephen I Walimbwa, Mohammed Lamorde, et al. · Antimicrobial Agents and Chemotherapy · 30

Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation

2015 · Laura Dickinson, H. Manisha Yapa, et al. · Antimicrobial Agents and Chemotherapy · 28

An Open Label, Adaptive, Phase 1 Trial of High‐Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS‐CoV‐2

2021 · Lauren E. Walker, Richard FitzGerald, et al. · Clinical Pharmacology & Therapeutics · 27

PDF

A Validated Method for Quantification of Dolutegravir Using Ultra Performance Liquid Chromatography Coupled With UV Detection

2016 · Xinzhu Wang, Sujan Dilly Penchala, et al. · Therapeutic Drug Monitoring · 26

Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

2022 · Richard FitzGerald, Laura Dickinson, et al. · Clinical Infectious Diseases · 24

PDF

Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots

2015 · Adeniyi Olagunju, Alieu Amara, et al. · Journal of Antimicrobial Chemotherapy · 24

PDF

Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019

2021 · Heli Harvala, Claire Reynolds, et al. · Sexually Transmitted Infections · 23

PDF

Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease

2016 · José Moltó, Fredzzia Graterol, et al. · Antimicrobial Agents and Chemotherapy · 19

Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adults

2025 · Michael Abouyannis, Yvonne K. Nyambura, et al. · EBioMedicine · 16

Works count: 67

Citation count: 1,105

H-index: 23

I10-index: 32